Asset Allocation
| Position | Category/Sector | Target Weight |
|---|---|---|
ABBNY ABB Ltd | Industrials | 4.33% |
AMLX Amylyx Pharmaceuticals, Inc. | Healthcare | 4.33% |
AQX.L Aquis Exchange plc | Financial Services | 8% |
AZN AstraZeneca PLC | Healthcare | 10% |
BNTX BioNTech SE | Healthcare | 4.33% |
NBIX Neurocrine Biosciences, Inc. | Healthcare | 4.33% |
NVO Novo Nordisk A/S | Healthcare | 10% |
NVS Novartis AG | Healthcare | 4.33% |
ORA.TO Aura Minerals Inc. | Basic Materials | 8% |
PBYI Puma Biotechnology, Inc. | Healthcare | 4.33% |
REL.L RELX PLC | Communication Services | 4.33% |
RGEN Repligen Corporation | Healthcare | 4.33% |
RHHBY Roche Holding AG | Healthcare | 10% |
SNY Sanofi | Healthcare | 4.33% |
STIP iShares 0-5 Year TIPS Bond ETF | Inflation-Protected Bonds | 15% |
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Dream Team, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.
Loading graphics...
The earliest data available for this chart is Jan 7, 2022, corresponding to the inception date of AMLX
Returns By Period
| 1D | 1M | YTD | 6M | 1Y | 3Y* | 5Y* | 10Y* | |
|---|---|---|---|---|---|---|---|---|
Benchmark S&P 500 Index | 0.44% | -1.90% | -3.41% | -1.91% | 30.31% | 17.22% | 10.14% | 12.44% |
Portfolio Dream Team | 0.17% | 0.42% | -0.46% | 0.66% | 26.80% | 14.48% | — | — |
| Portfolio components: | ||||||||
NVO Novo Nordisk A/S | -0.84% | -1.63% | -25.41% | -36.38% | -38.64% | -20.78% | 3.73% | 4.88% |
RHHBY Roche Holding AG | 0.26% | -6.91% | -0.02% | 13.67% | 36.95% | 13.31% | 7.79% | 7.80% |
AZN AstraZeneca PLC | -0.32% | 4.43% | 12.63% | 21.11% | 52.29% | 14.55% | 18.64% | 16.54% |
NVS Novartis AG | -0.77% | -1.64% | 14.23% | 19.09% | 48.79% | 20.76% | 16.39% | 11.34% |
SNY Sanofi | -0.61% | 6.85% | -1.77% | -4.24% | -4.37% | -1.31% | 3.04% | 5.31% |
ABBNY ABB Ltd | 0.79% | -0.76% | 13.67% | 13.86% | 79.27% | 38.41% | 24.25% | 19.51% |
REL.L RELX PLC | 0.75% | -5.64% | -17.83% | -28.50% | -31.04% | 3.02% | 7.79% | 8.46% |
BNTX BioNTech SE | 0.11% | -10.07% | -4.12% | -13.20% | 3.67% | -10.87% | -3.80% | — |
NBIX Neurocrine Biosciences, Inc. | 0.67% | 3.39% | -6.59% | -4.98% | 38.50% | 8.14% | 6.91% | 11.26% |
AMLX Amylyx Pharmaceuticals, Inc. | 5.82% | 14.22% | 30.96% | 24.67% | 361.22% | -18.35% | — | — |
Monthly Returns
Based on dividend-adjusted daily data since Jan 10, 2022, Dream Team's average daily return is +1,763.01%, while the average monthly return is +1.06%. At this rate, your investment would double in approximately 5.5 years.
Historically, 56% of months were positive and 44% were negative. The best month was Nov 2022 with a return of +11.8%, while the worst month was Sep 2022 at -6.7%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 4 months.
On a daily basis, Dream Team closed higher 52% of trading days. The best single day was Jul 1, 2025 with a return of +1,927,018.7%, while the worst single day was Jul 4, 2025 at -100.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 4.69% | -2.09% | -4.41% | 1.59% | -0.46% | ||||||||
| 2025 | 4.99% | 3.00% | -1.48% | 3.80% | 1.73% | -4.37% | -1.09% | 11.74% | 2.34% | 0.08% | 4.12% | 0.43% | 27.36% |
| 2024 | 1.15% | 1.36% | -1.38% | -0.57% | 4.17% | -0.06% | 6.70% | -1.10% | 2.02% | 0.01% | 7.23% | -5.68% | 13.98% |
| 2023 | 5.33% | -3.70% | 2.65% | 2.05% | -2.28% | -0.23% | 3.43% | -1.58% | -3.69% | -3.90% | 7.62% | 4.55% | 9.83% |
| 2022 | 0.07% | 2.96% | -0.99% | -6.09% | -0.76% | -0.68% | 4.78% | -3.09% | -6.69% | 6.54% | 11.78% | -1.91% | 4.51% |
Benchmark Metrics
- This portfolio captured 10301.31% of S&P 500 Index gains but only 51.98% of its losses — a favorable profile for investors.
- Beta of -221.48 may look defensive, but with R² of 0.00 this portfolio is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this portfolio's risk.
- R² of 0.00 means this portfolio moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Beta
- -221.48
- R²
- 0.00
- Upside Capture
- 10,301.31%
- Downside Capture
- 51.98%
Expense Ratio
Dream Team has an expense ratio of 0.01%, which is considered low. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.
Return for Risk
Risk / Return Rank
Dream Team ranks 43 for risk / return — on par with similar portfolios. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
| Portfolio | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.00 | 1.84 | -1.84 |
Sortino ratioReturn per unit of downside risk | 18,895.92 | 2.97 | +18,892.95 |
Omega ratioGain probability vs. loss probability | 9,710.52 | 1.40 | +9,709.12 |
Calmar ratioReturn relative to maximum drawdown | 0.24 | 1.82 | -1.58 |
Martin ratioReturn relative to average drawdown | 0.27 | 7.76 | -7.48 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
How much return does each position deliver for the risk it carries? Higher values mean better reward for the risk taken.
| Risk / Return Rank | Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Martin ratio | |
|---|---|---|---|---|---|---|
NVO Novo Nordisk A/S | 12 | -0.72 | -0.80 | 0.89 | -0.80 | -1.36 |
RHHBY Roche Holding AG | 75 | 1.33 | 2.05 | 1.25 | 1.60 | 5.16 |
AZN AstraZeneca PLC | 87 | 2.03 | 2.92 | 1.36 | 3.56 | 8.93 |
NVS Novartis AG | 90 | 2.37 | 3.11 | 1.40 | 3.92 | 11.36 |
SNY Sanofi | 27 | -0.16 | -0.04 | 0.99 | -0.44 | -0.86 |
ABBNY ABB Ltd | 94 | 2.98 | 4.25 | 1.53 | 3.97 | 16.00 |
REL.L RELX PLC | 7 | -1.03 | -1.37 | 0.81 | -0.67 | -1.46 |
BNTX BioNTech SE | 39 | 0.07 | 0.47 | 1.07 | -0.07 | -0.14 |
NBIX Neurocrine Biosciences, Inc. | 68 | 1.19 | 1.70 | 1.24 | 1.07 | 2.64 |
AMLX Amylyx Pharmaceuticals, Inc. | 98 | 5.12 | 4.69 | 1.56 | 11.40 | 26.54 |
Loading graphics...
Dividends
Dividend yield
Dream Team provided a 2.27% dividend yield over the last twelve months.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Portfolio | 2.27% | 2.10% | 2.04% | 2.03% | 2.61% | 2.79% | 1.37% | 1.78% | 1.87% | 1.63% | 1.87% | 1.37% |
| Portfolio components: | ||||||||||||
NVO Novo Nordisk A/S | 4.91% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
RHHBY Roche Holding AG | 3.19% | 2.69% | 3.87% | 3.55% | 3.23% | 1.57% | 1.66% | 1.70% | 3.58% | 3.25% | 3.57% | 2.91% |
AZN AstraZeneca PLC | 2.63% | 1.70% | 2.27% | 2.15% | 2.12% | 2.35% | 2.80% | 2.81% | 3.69% | 3.95% | 5.01% | 4.06% |
NVS Novartis AG | 3.12% | 2.90% | 3.84% | 3.44% | 3.70% | 3.86% | 3.22% | 3.03% | 3.47% | 3.24% | 3.73% | 3.10% |
SNY Sanofi | 4.65% | 4.56% | 4.22% | 3.83% | 4.32% | 3.80% | 3.61% | 3.47% | 4.29% | 3.82% | 4.11% | 3.77% |
ABBNY ABB Ltd | 1.47% | 1.39% | 1.79% | 2.07% | 2.88% | 2.29% | 2.77% | 3.31% | 4.35% | 2.84% | 3.47% | 4.21% |
REL.L RELX PLC | 2.55% | 2.13% | 1.65% | 1.80% | 2.24% | 1.99% | 2.55% | 2.27% | 2.48% | 2.15% | 2.25% | 2.21% |
BNTX BioNTech SE | 0.00% | 0.00% | 0.00% | 0.00% | 2.43% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NBIX Neurocrine Biosciences, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
AMLX Amylyx Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Dream Team. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Dream Team was 99.99%, occurring on Aug 5, 2025. The portfolio has not yet recovered.
The current Dream Team drawdown is 99.99%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.99% | Jul 2, 2025 | 25 | Aug 5, 2025 | — | — | — |
| -17.33% | Apr 8, 2022 | 121 | Sep 26, 2022 | 43 | Nov 24, 2022 | 164 |
| -12% | Apr 14, 2023 | 141 | Oct 27, 2023 | 41 | Dec 26, 2023 | 182 |
| -11.57% | Mar 18, 2025 | 16 | Apr 8, 2025 | 15 | Apr 30, 2025 | 31 |
| -10.4% | Jun 13, 2025 | 9 | Jun 25, 2025 | 4 | Jul 1, 2025 | 13 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Diversification
Diversification Metrics
Number of Effective Assets
The portfolio contains 15 assets, with an effective number of assets of 12.17, reflecting the diversification based on asset allocation. This number of effective assets suggests that the portfolio's investments are spread across a variety of assets, indicating a well-diversified allocation. However, true diversification also depends on the correlations between assets.
Asset Correlations Table
| Benchmark | STIP | ORA.TO | AQX.L | AMLX | NBIX | PBYI | REL.L | BNTX | NVO | SNY | RGEN | RHHBY | ABBNY | AZN | NVS | Portfolio | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Benchmark | 1.00 | 0.12 | 0.19 | 0.18 | 0.29 | 0.32 | 0.29 | 0.34 | 0.39 | 0.35 | 0.21 | 0.52 | 0.28 | 0.62 | 0.29 | 0.28 | 0.56 |
| STIP | 0.12 | 1.00 | 0.20 | 0.13 | 0.06 | 0.02 | 0.04 | 0.17 | 0.06 | 0.01 | 0.12 | 0.08 | 0.14 | 0.10 | 0.10 | 0.14 | 0.18 |
| ORA.TO | 0.19 | 0.20 | 1.00 | 0.15 | 0.08 | 0.06 | 0.06 | 0.11 | 0.08 | 0.06 | 0.06 | 0.09 | 0.12 | 0.21 | 0.11 | 0.09 | 0.38 |
| AQX.L | 0.18 | 0.13 | 0.15 | 1.00 | 0.04 | 0.05 | 0.08 | 0.26 | 0.11 | 0.09 | 0.13 | 0.16 | 0.15 | 0.25 | 0.15 | 0.18 | 0.35 |
| AMLX | 0.29 | 0.06 | 0.08 | 0.04 | 1.00 | 0.28 | 0.23 | 0.06 | 0.23 | 0.17 | 0.13 | 0.26 | 0.16 | 0.21 | 0.16 | 0.18 | 0.47 |
| NBIX | 0.32 | 0.02 | 0.06 | 0.05 | 0.28 | 1.00 | 0.17 | 0.10 | 0.23 | 0.20 | 0.15 | 0.27 | 0.20 | 0.18 | 0.23 | 0.24 | 0.40 |
| PBYI | 0.29 | 0.04 | 0.06 | 0.08 | 0.23 | 0.17 | 1.00 | 0.13 | 0.25 | 0.17 | 0.19 | 0.23 | 0.16 | 0.23 | 0.19 | 0.19 | 0.49 |
| REL.L | 0.34 | 0.17 | 0.11 | 0.26 | 0.06 | 0.10 | 0.13 | 1.00 | 0.11 | 0.22 | 0.21 | 0.22 | 0.29 | 0.36 | 0.28 | 0.31 | 0.36 |
| BNTX | 0.39 | 0.06 | 0.08 | 0.11 | 0.23 | 0.23 | 0.25 | 0.11 | 1.00 | 0.22 | 0.25 | 0.34 | 0.22 | 0.26 | 0.26 | 0.25 | 0.48 |
| NVO | 0.35 | 0.01 | 0.06 | 0.09 | 0.17 | 0.20 | 0.17 | 0.22 | 0.22 | 1.00 | 0.30 | 0.27 | 0.29 | 0.28 | 0.39 | 0.36 | 0.54 |
| SNY | 0.21 | 0.12 | 0.06 | 0.13 | 0.13 | 0.15 | 0.19 | 0.21 | 0.25 | 0.30 | 1.00 | 0.16 | 0.39 | 0.24 | 0.50 | 0.52 | 0.45 |
| RGEN | 0.52 | 0.08 | 0.09 | 0.16 | 0.26 | 0.27 | 0.23 | 0.22 | 0.34 | 0.27 | 0.16 | 1.00 | 0.22 | 0.36 | 0.22 | 0.21 | 0.51 |
| RHHBY | 0.28 | 0.14 | 0.12 | 0.15 | 0.16 | 0.20 | 0.16 | 0.29 | 0.22 | 0.29 | 0.39 | 0.22 | 1.00 | 0.31 | 0.49 | 0.56 | 0.54 |
| ABBNY | 0.62 | 0.10 | 0.21 | 0.25 | 0.21 | 0.18 | 0.23 | 0.36 | 0.26 | 0.28 | 0.24 | 0.36 | 0.31 | 1.00 | 0.29 | 0.31 | 0.50 |
| AZN | 0.29 | 0.10 | 0.11 | 0.15 | 0.16 | 0.23 | 0.19 | 0.28 | 0.26 | 0.39 | 0.50 | 0.22 | 0.49 | 0.29 | 1.00 | 0.57 | 0.56 |
| NVS | 0.28 | 0.14 | 0.09 | 0.18 | 0.18 | 0.24 | 0.19 | 0.31 | 0.25 | 0.36 | 0.52 | 0.21 | 0.56 | 0.31 | 0.57 | 1.00 | 0.53 |
| Portfolio | 0.56 | 0.18 | 0.38 | 0.35 | 0.47 | 0.40 | 0.49 | 0.36 | 0.48 | 0.54 | 0.45 | 0.51 | 0.54 | 0.50 | 0.56 | 0.53 | 1.00 |